Infection with SARS-CoV-2 leads to respiratory disease, which can result in lung failure in severe cases. It is then usually necessary to provide invasive ventilation to the affected patients. Simultaneously, complications such as pulmonary embolism or thrombosis in the veins...

Read more

A study conducted by Charité – Universitätsmedizin Berlin found that blood pressure medications have the same effect on COVID-19 patients as they do on people without the disease.

Read more

The Frankfurt heart researcher and director of the Institute of Cardiovascular Medicine at the Center for Molecular Medicine at Goethe University, Professor Stefanie Dimmeler, is honored with the Gold Medal of the European Society of Cardiology. Stefanie Dimmeler is a Principal...

Read more

The EAST-AFNET 4 study provides new evidence on how atrial fibrillation can best be treated in early stages: Therapies that stabilise the heart rhythm can reduce the risk of strokes and severe secondary damage.

Read more

Cardiologists from the DZHK partner sites Rhine-Main and Berlin find SARS-CoV-2 in the heart muscle of patients with myocarditis by biopsy - also with overcome COVID-19 disease.

Read more

DZHK Scientists at the Heart Center of the University Medical Center Göttingen have for the first time found an approach for a personalised therapy option with "gene editing" for the Noonan Syndrome. The results were published in the renowned journal "Circulation".

Read more

Healthy ageing begins with a healthy pregnancy. It starts with healthy blood pressure values. Scientists of the German Centre for Cardiovascular Research (DZHK), together with Danish colleagues, have found that increased blood pressure during pregnancy is transmitted to the...

Read more

The majority of patients recovered from COVID-19 have inflammatory changes in the heart two months after the start of the disease. A team led by Valentina Puntmann and Eike Nagel from the University Hospital Frankfurt has demonstrated this by using magnetic resonance imaging. The...

Read more

A group of researchers from Goethe University and University Hospital Frankfurt demonstrates that an inhibitor against microRNA-92a is effective in humans. The German Centre for Cardiovascular Research (DZHK) supported this clinical trial.

Read more

A surprising finding by scientists from the University Medical Center Hamburg-Eppendorf (UKE) reveals that the coronavirus can attack the heart and alter the gene activity of infected heart cells. That is the result of a recent study by DZHK scientist Prof. Dr. Dirk Westermann...

Read more